Home >> Tag Archives: Crescendo Bioscience—

Tag Archives: Crescendo Bioscience—

Crescendo launches site for RA patients

May 17, 2016—Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, has launched a website called myVectra for patients with rheumatoid arthritis. The site aims to provide patients with easy access to their Vectra DA test results and test history, which can help them to prepare for visits with their rheumatologist. Patients will have access to their results in the portal ...

Read More »

Rheumatoid arthritis test, 7/13:105

Crescendo Bioscience announced that the Wadsworth Center at the New York Department of Health, through its Clinical Laboratory Evaluation Program, issued a laboratory permit to Crescendo Bioscience to provide services to physicians in New York. Crescendo offers Vectra DA, a multi-biomarker blood test that measures disease activity in rheumatoid arthritis by integrating 12 key proteins consistently associated with the biology ...

Read More »